Mecanismos de señalización celular en enfermedades hepáticas, cardiovasculares y cáncer
![Foto de Mecanismos de señalización celular en enfermedades hepáticas, cardiovasculares y cáncer](/img/grupo.png)
![Foto de Centro Nacional de Investigaciones Oncológicas](/img/noimage_org.png)
Centro Nacional de Investigaciones Oncológicas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (11)
2024
2022
-
Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC-induced cholestatic injury by promoting a pro-restorative inflammatory response
Journal of Pathology, Vol. 258, Núm. 3, pp. 312-324
2020
2018
-
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
Nature Communications, Vol. 9, Núm. 1
2013
-
Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies
Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 34, pp. 13791-13796
-
The transforming growth factor-beta (TGF-β) in liver fibrosis
TGF-β in Human Disease (Springer Japan), pp. 255-277
2009
-
p53 regulates the self-renewal and differentiation of neural precursors
Neuroscience, Vol. 158, Núm. 4, pp. 1378-1389
2008
-
A role for p38α mitogen-activated protein kinase in embryonic cardiac differentiation
FEBS Letters, Vol. 582, Núm. 7, pp. 1025-1031
2007
-
Negative regulation of Akt activity by p38α MAP kinase in cardiomyocytes involves membrane localization of PP2A through interaction with caveolin-1
Cellular Signalling, Vol. 19, Núm. 1, pp. 62-74
-
p38α MAPK can positively or negatively regulate Rac-1 activity depending on the presence of serum
FEBS Letters, Vol. 581, Núm. 20, pp. 3819-3825
2006
-
Enhanced antiangiogenic therapy with antibody-collagen XVIII NC1 domain fusion proteins engineered to exploit matrix remodeling events
International Journal of Cancer, Vol. 119, Núm. 2, pp. 455-462